REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/03/2026
Back to search
Official data from USPTO
COVIG-19
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
COVIG-19
ST13
US500000090218133Class
5, 42, 44
Filing
90218133
Registration
6437981
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
08/03/2026
Trademark type
Word
Nice classes
5, 42, 44
Filing date
09/28/2020
Registration date
08/03/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/03/2021
Last transaction
08/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
Glattpark-Opfikon, CH
Examiner
BAKER, JORDAN A
Law office
O30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Takeda Pharmaceuticals International AG
Representatives
Karl M. Zielaznicki, Esq. TROUTMAN PEPPER HAMILTON SANDERS LLP
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment and immunization of coronavirus diseases; blood for medical purposes; blood components for medical purposesin particular blood plasma
Class 42
Scientific research services in the field of pharmaceuticals related to the treatment and immunization of coronavirus diseases; blood analysis services
Class 44
Blood bank services; medical services and paramedical servicescollection of bloodproviding transfusions of blood and blood components
Publications
History of USPTO decisions and trademark events.
29 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/03/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/18/2021
PUBO
PUBLISHED FOR OPPOSITION
05/18/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/28/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/14/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
04/14/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/14/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
04/14/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/14/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/13/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/13/2021
ALIE
ASSIGNED TO LIE
04/07/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
01/07/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/04/2021
GNSL
LETTER OF SUSPENSION E-MAILED
01/04/2021
CNSL
SUSPENSION LETTER WRITTEN
01/04/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/23/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/22/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/22/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/30/2020
GNRT
NON-FINAL ACTION E-MAILED
10/30/2020
CNRT
NON-FINAL ACTION WRITTEN
10/30/2020
DOCK
ASSIGNED TO EXAMINER
10/29/2020
PCGR
PETITION TO DIRECTOR GRANTED
10/29/2020
APET
ASSIGNED TO PETITION STAFF
10/29/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/28/2020
TPDR
TEAS PETITION TO DIRECTOR RECEIVED
10/12/2020
NWAP
NEW APPLICATION ENTERED
10/01/2020
Continuous trademark protection
Get notified about every new filing that threatens COVIG-19 or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.